MARY GRACE GOROSPE: Open Payments
NPI 1477828150 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,579 in 104 payments from 20 companies in 2025. Trend: 2023 $2,391 · 2024 $3,316 · 2025 $2,579
Food & beverage: $2,483Education: $96
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $561 |
| GlaxoSmithKline, LLC. | 21 | $392 |
| United Therapeutics Corporation | 7 | $240 |
| Astellas Pharma US Inc | 6 | $215 |
| Amgen Inc. | 11 | $174 |
| Pulmonx Corporation | 1 | $161 |
| ABBVIE INC. | 5 | $114 |
| ViiV Healthcare Company | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Verona Pharma, Inc. | 4 | $90 |
Products named: NUCALA, DUPIXENT, AIRSUPRA, TEZSPIRE, CHARTIS CATHETER, TRELEGY ELLIPTA, AmBisome, FASENRA.
Industry payments across CA — which companies pay providers there.
